Nubia Boechat Andrade

Senior specialist at Fundação Oswaldo Cruz (FIOCRUZ), where she is the head of organic chemistry group dedicated to drug synthesis. She has published more than 140 papers, 8 book chapters and nothing less than 47 patents. During her 36 years as a researcher at Fiocruz, Dr. Adnrade played a key role to improve public health in Brazil through the design of novel synthetic routes to generic drugs. Among the awards she received, the Walter Baptist Mors medal (2018) and the Brazilian Women in Chemistry ACS-SBQ (2021) highlight her undisputed contribution to the brazilian medicinal chemistry comunity

Lack of in-house API production in a world devastated by pandemic and war: impact on public pharmaceutical production

Historically, Brazil lacks the production of Active Pharmaceutical Ingredients (API) which are the basis for domestic pharmaceutical production. This deficiency has been seriously affected by the pandemic and by the war in Europe. Here we present a brief history, the current status, and the impact of the lack of API on public pharmaceutical production in Brazil. Our experience in the development and innovation of APIs will be shown, trying to meet the needs of our Unified Health System (SUS).